- Issuer ticker
-
CYTK
- Reported as of
-
01 Jun 2026
- Net transaction value
-
-$370,400
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
01 Jun 2026, 18:49:17 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ John O. Faurescu, attorney-in-fact for Ms. Parshall
Key filing fact
B. Lynne Parshall filed Form 4 for CYTOKINETICS INC (CYTK) on 01 Jun 2026.
Key facts
- This page summarizes B. Lynne Parshall's Form 4 filing for CYTOKINETICS INC (CYTK).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2026, 18:49.
Change
- Previous filing in this sequence was filed on 27 May 2026.
- Current net transaction value: -$370,400.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001073385
Primary reporting owner
PARSHALL B LYNNE
- Relationship
-
Director
- Address
- 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
- Signature
- /s/ John O. Faurescu, attorney-in-fact for Ms. Parshall
- Signature date
- 01 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTK
transaction
Common Stock
Sale
- Transaction value
- $370,400
- Shares
- -5,000
- Change %
- -24%
- Price
-
$74.08
- Shares after
- 15,784
- Date
- 01 Jun 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).